GSEA analysis was used to further understand AURKA-related as well as FAM83A-related pathways. AURKA and FAM83A expression levels were used to grouping the LUAD patients in an independent TCGA cohort, samples with the expression levels were higher than the median value of both AURKA and FAM83A expression were assigned to the high expression group, rest of the samples are defined as low expression group automatically. The collection of annotated gene sets of c2.cp.kegg.v6.2.symbols.gmt was used to the reference gene sets and GSEA software was used to preform GSEA analysis. The cut-off criterion is FDR< 0.01.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.